Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,101.9
9.8 (0.32%)

 

  • STI Straits Times Index
    3,101.9
    9.8 (0.32%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,501.7
    4.8 (0.32%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    23,766.7
    -22.2 (-0.09%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,607.4
    33.6 (0.94%)
    Index delayed 15 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 818.5M
  • Value: 1,115.1M
  • Rise: 182
  • Fall: 131
  • Unch: 448

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Sembcorp Marine0.083-
Genting Sing0.760+0.015
SingHaiyi0.117-
CapLand IntCom T2.060-0.010
Singtel2.380-
Metal Component0.047-0.003
HGH0.019-
Golden Agri-Res0.235+0.010
HPH Trust USD0.230+0.005
Mapletree Log Tr1.870-

World Indices

World Indices
Name Last Change
Nasdaq 15,537.7 -245.1
HSI 23,766.7 -22.2
HSCEI 8,455.5 -50.9
Jakarta 6,538.5 -45.3
Nikkei 225 27,935.6
SSE Comp 3,607.4 +33.6
Shanghai A 3,781.0 +35.2
Shanghai B 286.0 +2.9
KOSPI 2,968.3 +23.1

Nikkei 225 updated at end-of-day. Other Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

Lonza LONZA GROUP LTD
Quotes 10 Minutes Delayed. Updated at 03 Dec 2021 07:12
Last (SGD): 79.970 Change: - High: - Remarks: -
Change (%): - Low: -

Company Background

Lonza Group Ltd is a corporation incorporated under the laws of Switzerland and has been listed on the SIX Swiss Exchange (the “SIX”) since November 1999.Lonza is a supplier to the pharmaceutical, healthcare and life sciences industries with products and services spanning from research to final product manufacture to meet customers' needs. The products Lonza manufacture for the life sciences industry can be characterised as very complex molecules which are manufactured in a highly regulated environment and will end up in the body of human beings or animals.Biopharmaceuticals are one of the key growth drivers of the pharmaceutical and biotechnology industries. The Group has strong capabilities in large and small molecules, peptides, amino acids and niche bioproducts which play an important role in the development of novel medicines and healthcare products. The Group provides cell-based research, endotoxin detection and cell therapy manufacturing. The Group is also a provider of high value chemicals and biotech ingredients to the nutrition, hygiene, preservation, agro and personal care markets.To provide optimal support to its customers, the Group is organized into three business divisions, namely, Custom Manufacturing, Life Science Ingredients and Bioscience, which focus on specific sets of customers and their needs.

Click to show Stock Prices chart

Key Statistics

EPS (SGD) a 17.53723 Trailing EPS (SGD) b 14.40184 NAV (SGD) c 142.7612
PE a 4.560 Trailing PE d 5.553 Price / NAV c 0.5602
Dividend Yield (%) e 5.624 Cash In Hand (SGD) f 9.8422 Issued & Paid-up Shares g 74,283,000
Piotroski F Score 6 Market Cap (M) 5,940.412 Free Float (%) 99.9
Return on Equity (ROE) (%) h 10.088 Revenue Growth (%) TTM i -30.741
Net Earnings Growth (%) j -9.464 Net Debt/Equity k 0.433
Under CPF Investment Scheme (CPFIS) No
Sector & Industry Manufacturing - Biotechnology
Category Classification Foreign Listing (Others) / Medical & Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted based on Profit Attributable To Shareholders.
  2. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  3. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  4. Based on latest Full Year results announcement, adjusted for the current number of shares.
  5. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  6. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  7. Rounded to the nearest thousand. The figure pertains to the respective exchange the stock is listed on. Updated on 28 Jun 2021. Please click here for more information.
  8. Calculated based on Net Earnings / (Shareholders' Equity - Other Share Capital)
  9. Calculated based on (Current Year Revenue - Last Year Revenue) / Last Year Revenue
  10. Calculated based on (Current Year Earnings - Last Year Earnings) / Last Year Earnings
  11. Calculated based on (Long Term Debt + Short Term Debt - Cash and Short Term Investments)/(Shareholders' Equity - Other Share Capital)

Total Shareholder Return

Not enough data to show total shareholder returns
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference Lonza SGX 5,940.412 4.560 5.553 0.5602 5.624
Industry Biotechnology SGX 2,976.011 4.569 5.564 0.5603 5.613
Foreign Listing (Others) SGX 10,743.411 15.649 21.705 2.3764 2.521
Medical & Biotechnology SGX 1,027.291 18.959 16.114 1.4732 1.912
Local Peer Suntar Eco-City SGX 11.611 462.500 3870.293 0.6227 -
Global Peer AMGEN INC HKEx 991,911.426 17.606 22.779 15.5067 2.894
Global Peer MODERNA INC NASDAQ 122,239.121 - 17.311 12.0742 -
Global Peer CSL LTD ASX 135,639.884 42.602 42.602 12.1498 0.986
Global Peer GILEAD SCIENCES INC NASDAQ 87,392.655 710.483 11.819 4.0705 3.903
Global Peer BIONTECH SE SPON ADS EACH REP 1 ORD SHS NASDAQ 80,544.838 4,649.240 9.008 7.9778 -
Global Peer REGENERON PHARMACEUTICALS INC NASDAQ 68,198.727 19.412 9.749 3.9517 -
Global Peer ILLUMINA INC NASDAQ 55,874.124 85.174 61.671 5.2746 -
Global Peer WUXI BIOLOGICS (CAYMAN) INC HKEx 438,123.216 230.862 132.738 10.9731 -
Global Peer VERTEX PHARMACEUTICAL NASDAQ 51,981.821 19.170 23.887 5.4541 -
Global Peer BIOGEN INC NASDAQ 33,567.988 8.391 21.716 3.2184 -
Other Global Peers BEIGENE LTD (HKEx), BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS (NASDAQ), SEAGEN INC (NASDAQ), ALNYLAM PHARMACEUTICALS INC (NASDAQ), BIO-TECHNE CORP (NASDAQ), 10X GENOMICS INC (NASDAQ), GINKGO BIOWORKS HOLDINGS INC (NYSE), BIOMARIN PHARMACEUTICAL (NASDAQ), INCYTE CORPORATION (NASDAQ), EXACT SCIENCES CORP (NASDAQ), SINO BIOPHARMACEUTICAL (HKEx), NOVAVAX INC (NASDAQ), GENSCRIPT BIOTECH CORPORATION (HKEx), INTELLIA THERAPEUTICS INC (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), ZAI LAB LIMITED (HKEx), VIR BIOTECHNOLOGY INC (NASDAQ), BRIDGEBIO PHARMA INC (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), EXELIXIS INC (NASDAQ), ABCAM PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), FATE THERAPEUTICS (NASDAQ), BEAM THERAPEUTICS INC (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), KODIAK SCIENCES INC (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), JOINN LABORATORIES (CHINA) CO LTD (HKEx), ABCELLERA BIOLOGICS INC (NASDAQ), ARVINAS INC (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), ALKERMES PLC (NASDAQ), ZENTALIS PHARMACEUTICALS INC (NASDAQ), 23ANDME HOLDING CO (NASDAQ), SANA BIOTECHNOLOGY INC (NASDAQ), VALNEVA SE SPON ADS EACH REPR 2 ORD SHS (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), RECURSION PHARMACEUTICALS INC (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), CYTOKINETICS INC (NASDAQ), INSMED INC (NASDAQ), RELAY THERAPEUTICS INC (NASDAQ), GALAPAGOS NV SPON ADR REPR 1 ORD SHS (NASDAQ), ARCUS BIOSCIENCES INC (NYSE), INTRA-CELLUAR THERAPIES INC (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), INSTIL BIO INC (NASDAQ), VERACYTE INC (NASDAQ), KYMERA THERAPEUTICS INC (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), KINTOR PHARMACEUTICAL LTD (HKEx), PTC THERAPEUTICS INC (NASDAQ), LIGAND PHARMACEUTICAL INC (NASDAQ), AURINIA PHARMACEUTICALS INC (NASDAQ), CHEMOCENTRYX INC (NASDAQ), TG THERAPEUTICS INC (NASDAQ), OLINK HLDG AB SPON ADS EACH REP 1 ORD SHS (NASDAQ), LYELL IMMUNOPHARMA INC (NASDAQ), PROTHENA CORP PLC (NASDAQ), 3SBIO INC (HKEx), ALPHAMAB ONCOLOGY (HKEx), XENCOR INC (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), IMUGENE LIMITED (ASX), EDITAS MEDICINE INC (NASDAQ), MYRIAD GENETICS INC (NASDAQ), NUVATION BIO INC (NYSE), AVID BIOSERVICES INC (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), NANOSTRING TECHNOLOGIES INC (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), C4 THERAPEUTICS INC (NASDAQ), TRAVERE THERAPEUTICS INC (NASDAQ), MORPHIC HOLDING INC (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), IVERIC BIO INC (NASDAQ), BICYCLE THERAPEUTICS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), SORRENTO THERAPEUTICS INC (NASDAQ), ALECTOR INC (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), KRYSTAL BIOTECH INC (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), ROCKET PHARMACEUTICALS INC (NASDAQ), INHIBRX INC (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), IMMUNOGEN INC (NASDAQ), JACOBIO PHARMACEUTICALS GRP CO LTD (HKEx), MYOVANT SCIENCES LTD (NYSE), COHERUS BIOSCIENCES INC (NASDAQ), IMMUNOCORE HLDGS PLC SPON ADS EACH REP ONE ORD SHS (NASDAQ), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), REPLIMUNE GROUP INC (NASDAQ), REGENXBIO INC (NASDAQ), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), SEER INC (NASDAQ), COMPASS PATHWAYS PLC UNSPON ADS REP 1 ORD SHS (NASDAQ), TELIX PHARMACEUTIC (ASX), FRONTAGE HOLDINGS CORP (HKEx), VIVA BIOTECH HOLDINGS (HKEx), FIBROGEN INC (NASDAQ), UNIQURE N.V. (NASDAQ), RANI THERAPEUTICS HLDGS INC (NASDAQ), OCUGEN INC (NASDAQ), ORGANOGENESIS HOLDINGS INC (NASDAQ), ITEOS THERAPEUTICS INC (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), SHANGHAI HAOHAI BIOLOGICAL TECH CO (HKEx), DICE THERAPEUTICS INC (NASDAQ), ALLOVIR INC (NASDAQ), VAXXINITY INC (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), AVIDITY BIOSCIENCES INC (NASDAQ), HUMACYTE INC (NASDAQ), MANNKIND CORPORATION (NASDAQ), MERUS B V (NASDAQ), LIANBIO SPON ADS EACH REPR 1 ORD SHS (NASDAQ), CARIBOU BIOSCIENCES INC (NASDAQ), VAXCYTE INC (NASDAQ), PURETECH HEALTH PLC SPON ADS EACH REP 10 ORD SHS (NASDAQ), BIONANO GENOMICS INC (NASDAQ), MACROGENICS INC (NASDAQ), MAXCYTE INC (NASDAQ), SERES THERAPEUTICS (NASDAQ), ASCENTAGE PHARMA GROUP INTL (HKEx), NUVALENT INC (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), RAPT THERAPEUTICS INC (NASDAQ), VENTYX BIOSCIENCES INC (NASDAQ), VANDA PHARMACE INC (NASDAQ), IMMUNOVANT INC (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), KURA ONCOLOGY INC (NASDAQ), STOKE THERAPEUTICS INC (NASDAQ), ANAPTYSBIO INC (NASDAQ), ENTRADA THERAPEUTICS INC (NASDAQ), MERIDIAN BIOSCIENCE INC COM (NASDAQ), OMEGA THERAPEUTICS INC (NASDAQ), BIOATLA INC (NASDAQ), VAXART INC (NASDAQ), PRECIGEN INC (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), EDGEWISE THERAPEUTICS INC (NASDAQ), MONTE ROSA THERAPEUTICS INC (NASDAQ), SYNDAX PHARMACEUTICALS INC (NASDAQ), MIMEDX GROUP INC (NASDAQ), AFFIMED N V (NASDAQ), AGENUS INC (NASDAQ), RADIUS HEALTH INC (NASDAQ), IMAGO BIOSCIENCES INC (NASDAQ), MESOBLAST LTD (ASX), BLUEBIRD BIO INC (NASDAQ), 4D MOLECULAR THERAPEUTICS INC (NASDAQ), KEZAR LIFE SCIENCES INC (NASDAQ), PACIFIC EDGE LIMITED (ASX), IMMATICS N V (NASDAQ), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), VBI VACCINES INC CDA (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), PRELUDE THERAPEUTICS INC (NASDAQ), JANUX THERAPEUTICS INC (NASDAQ), POLYNOVO LIMITED (ASX), DYNE THERAPEUTICS INC (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), NAUTILUS BIOTECHNOLOGY INC (NASDAQ), APPLIED MOLECULAR TRANSPORT INC (NASDAQ), JW (CAYMAN) THERAPEUTICS CO. LTD (HKEx), VERA THERAPEUTICS INC. (NASDAQ), THESEUS PHARMACEUTICALS INC (NASDAQ), ENOCHIAN BIOSCIENCES INC (NASDAQ), PERSONALIS INC (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC SPON ADS EACH REP 6 ORD SHS (NASDAQ), INVENTIVA SA SPON ADS EACH REP 1 ORD SHS (NASDAQ), AURA BIOSCIENCES INC (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), ACTINIUM PHARMACEUTICALS INC (NYSE American), PRECISION BIOSCIENCES INC (NASDAQ), GRAPHITE BIO INC (NASDAQ), CHIMERIX INC (NASDAQ), TAYSHA GENE THERAPIES INC (NASDAQ), SUMMIT THERAPEUTICS INC (NASDAQ), GENOR BIOPHARMA HLDGS LTD (HKEx), NKARTA INC (NASDAQ), ATHIRA PHARMA INC (NASDAQ), VOR BIOPHARMA INC (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), GRACELL BIOTECHNOLOGIES INC SPON ADS EACH REP 5 ORD SHS (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), PLIANT THERAPEUTICS INC (NASDAQ), VERASTEM INC (NASDAQ), AKOYA BIOSCIENCES INC (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), IKENA ONCOLOGY INC (NASDAQ), SINOVAC BIOTECH LTD (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), OMEROS CORP (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), POSEIDA THERAPETUICS INC (NASDAQ), CYTOMX THERAPEUTICS INC (NASDAQ), RIGEL PHARMACEUTICALS INC (NASDAQ), GERON CORP (NASDAQ), ASCLETIS PHARMA INC (HKEx), MOLECULAR PARTNERS AG SPON ADS EACH REP 1 ORD SHS (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), CURIS INC (NASDAQ), BELLUS HEALTH INC (NASDAQ), ALDEYRA THERAPEUTICS (NASDAQ), CORTEXYME INC (NASDAQ), PASSAGE BIO INC (NASDAQ), AADI BIOSCIENCE INC (NASDAQ), FOGHORN THERAPEUTICS INC (NASDAQ), VIRIDIAN THERAPEUTICS INC (NASDAQ), VIKING THERAPEUTICS INC (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), 22ND CENTURY GROUP INC (NASDAQ), ALTIMMUNE INC (NASDAQ), ESSEX BIO-TECHNOLOGY (HKEx), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), CUE BIOPHARMA INC (NASDAQ), JOUNCE THERAPEUTICS INC (NASDAQ), GREENWICH LIFESCIENCES INC (NASDAQ), HUMANIGEN INC (NASDAQ), SHATTUCK LABS INC (NASDAQ), INNATE PHARMA SPON ADS EACH REP 1 ORD SHS (NASDAQ), SINOMAB BIOSCIENCE LTD (HKEx), COMPUGEN (NASDAQ), LINEAGE CELL THERAPEUTICS INC (NYSE American), DPHARMA (Bursa), VISTAGEN THERAPEUTICS INC (NASDAQ), XBIOTECH INC (NASDAQ), RAIN THERAPEUTICS INC (NASDAQ), SELECTA BIOSCIENCES INC (NASDAQ), SIERRA ONCOLOGY INC (NASDAQ), AMBRX BIOPHARMA INC SPON ADS EACH REP 7 ORD SHS (NYSE), LONGEVERON INC (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), TIZIANA LIFE SCIENCES LTD (NASDAQ), ADICET BIO INC (NASDAQ), SQZ BIOTECHNOLOGIES CO (NYSE), CABALETTA BIO INC (NASDAQ), MAGENTA THERAPEUTICS INC (NASDAQ), EPIZYME INC (NASDAQ), COGENT BIOSCIENCES INC (NASDAQ), AEROVATE THERAPEUTICS INC (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), OUTLOOK THERAPEUTICS INC (NASDAQ), AKOUOS INC (NASDAQ), AEGLEA BIOTHERAPEUTICS INC (NASDAQ), JASPER THERAPEUTICS INC (NASDAQ), ELIEM THERAPEUTICS INC (NASDAQ), IMMUTEP LTD SPON ADS EACH REP 10 ORD SHS (NASDAQ), NANOVIRICIDES INC (NYSE American), IMMUTEP LTD (ASX), ZIOPHARM ONCOLOGY INC (NASDAQ), CYMABAY THERAPEUTICS INC (NASDAQ), OPTHEA LIMITED SPON ADS EACH REPR 8 ORD SHS (NASDAQ), KAMADA LTD (NASDAQ), OPTHEA LIMITED (ASX), HOMOLOGY MEDICINES INC (NASDAQ), HARVARD BIOSCIENCE INC (NASDAQ), UROGEN PHARMA LTD (NASDAQ), ANTEOTECH LIMITED (ASX), ADMA BIOLOGICS INC (NASDAQ), FORTRESS BIOTECH INC (NASDAQ), LEES PHARMACEUTICAL HLDGS (HKEx), ESPERION THERAPEUTICS INC (NASDAQ), SURFACE ONCOLOGY INC (NASDAQ), SPECTRUM PHARMACEUTICALS INC (NASDAQ), LANDOS BIOPHARMA INC (NASDAQ), ATHERSYS INC (NASDAQ), XERIS BIOPHARMA HLDGS INC (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), CO DIAGNOSTICS INC (NASDAQ), 9 METERS BIOPHARMA INC (NASDAQ), PIERIS PHARMACEUTICALS INC (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), IO BIOTECH INC (NASDAQ), BLACK DIAMOND THERAPEUTICS INC (NASDAQ), ATYR PHARMA INC (NASDAQ), NEOLEUKIN THERAPEUTICS INC (NASDAQ), LEAP THERAPEUTICS INC (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), INMUNE BIO INC (NASDAQ), ASPIRA WOMENS HEALTH INC (NASDAQ), INFLARX N V (NASDAQ), EIGER BIOPHARMACEUTICALS INC (NASDAQ), PARATEK PHARMACEUTICALS INC (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), IMMUNOME INC (NASDAQ), SESEN BIO INC (NASDAQ), AVEO PHARMACEUTICALS INC (NASDAQ), SOLID BIOSCIENCES INC (NASDAQ), COGNITION THERAPEUTICS INC (NASDAQ), SENSEI BIOTHERAPEUTICS INC (NASDAQ), TERNS PHARMACEUTICALS INC (NASDAQ), ARDELYX INC (NASDAQ), PORTAGE BIOTECH INC (NASDAQ), EDAP TMS S.A. SPON ADR EACH REPR 1 ORD SHARE (NASDAQ), APTOSE BIOSCIENCES INC (NASDAQ), FREQUENCY THERAPEUTICS INC (NASDAQ), SEELOS THERAPEUTICS INC (NASDAQ), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), INFINITY PHARMACEUTICALS INC (NASDAQ), LAVA THERAPEUTICS NV (NASDAQ), NEXT SCIENCE LTD (ASX), LARIMAR THERAPEUTICS INC (NASDAQ), NEXTCURE INC (NASDAQ), SYNLOGIC INC (NASDAQ), ENZO BIOCHEM INC (NYSE), VIRACTA THERAPEUTICS INC (NASDAQ), DECIBEL THERAPEUTICS INC (NASDAQ), NEUREN PHARMACEUTICALS LTD (ASX), AVROBIO INC (NASDAQ), BETTER THERAPEUTICS INC (NASDAQ), MEDICINOVA INC (NASDAQ), BRIACELL THERAPEUTICS CORP (NASDAQ), ONCORUS INC (NASDAQ), ACTINOGEN MEDICAL LTD (ASX), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), ELEVATION ONCOLOGY INC (NASDAQ), RENOVACOR INC (NYSE American), GALECTIN THERAPEUTICS INC (NASDAQ), BIOVIE INC (NASDAQ), MDXHEALTH SPON ADS EACH REP 10 ORD SHARE (NASDAQ), MIROMATRIX MEDICAL INC (NASDAQ), VASCULAR BIOGENICS LTD (NASDAQ), WANG ON GROUP (HKEx), OPIANT PHARMACEUTICALS INC (NASDAQ), EQUILLIUM INC (NASDAQ), ATRECA INC (NASDAQ), ARMATA PHARMACEUTICALS INC (NYSE American), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), KAZIA THERAPEUTICS LIMITED (ASX), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), BRAINSTROM CELL THERAPEUTICS (NASDAQ), CARDIOL THERAPEUTICS INC (NASDAQ), CONTRAFECT CORP (NASDAQ), SAVARA INC (NASDAQ), PUMA BIOTECHNOLOGY INC (NASDAQ), IMV INC (NASDAQ), CASI PHARMACEUTICALS INC (NASDAQ), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), CONCERT PHARMACEUTICALS INC (NASDAQ), OTONOMY INC (NASDAQ), IN8BIO INC (NASDAQ), TREVENA INC (NASDAQ), GEMINI THERAPEUTIC (NASDAQ), CHAMPIONS ONCOLOGY INC (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), FENNEC PHARMACEUTICALS INC (NASDAQ), SIO GENE THERAPIES INC (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), IMMUNOPRECISE ANTIBODIES LTD (NASDAQ), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), PRESCIENT THERAPEUTICS LIMITED (ASX), AXCELLA HEALTH INC (NASDAQ), MAINZ BIOMED B V (NASDAQ), HEAT BIOLOGICS INC (NASDAQ), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), LA JOLLA PHARMACEUTICAL CO (NASDAQ), SIGILON THERAPEUTICS INC (NASDAQ), HCW BIOLOGICS INC (NASDAQ), DYADIC INTERNATIONAL INC (NASDAQ), X4 PHARMACEUTICALS INC (NASDAQ), CHEMOMAB THERAPEUTICS LTD SPON ADS EACH REP 20 ORD SHS (NASDAQ), T2 BIOSYSTEMS INC (NASDAQ), CIDARA THERAPEUTICS INC (NASDAQ), ANIXA BIOSCIENCES INC (NASDAQ), MATINAS BIOPHARMA HOLDINGS INC (NYSE American), EVAXION BIOTECH AS SPON ADS EACH REP 1 ORD SHS (NASDAQ), MEDICENNA THERAPEUTICS CORP (NASDAQ), MARKER THERAPEUTICS INC (NASDAQ), DIAMEDICA THERAPEUTICS INC (NASDAQ), CEL-SCI CORP (NYSE American), ONCOLYTICS BIOTECH INC (NASDAQ), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), LEAF RESOURCES LTD (ASX), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), PALATIN TECHNOLOGIES INC (NYSE American), GLYCOMIMETICS INC (NASDAQ), AVALON GLOBOCARE CORP (NASDAQ), ITERUM THERAPEUTICS PLC (NASDAQ), FREELINE THERAPEUTICS HLDGS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), STATERA BIOPHARMA INC (NASDAQ), GAIN THERAPEUTICS INC (NASDAQ), BIONOMICS LTD (ASX), EVOGENE LTD (NASDAQ), CHECKMATE PHARMACEUTICALS INC (NASDAQ), PLURISTEM THERAPEUTICS INC (NASDAQ), ORGENESIS INC (NASDAQ), UNI-BIO SCIENCE GROUP LIMITED (HKEx), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), CAPRICOR THERAPEUTICS INC (NASDAQ), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), GENOCEA BIOSCIENCES INC (NASDAQ), RECRO PHARMA INC (NASDAQ), IBIO INC (NYSE American), AIM IMMUNOTECH INC (NYSE American), ACHIEVE LIFE SCIENCE INC (NASDAQ), EVOFEM BIOSCIENCES INC (NASDAQ), ASTRIA THERAPEUTICS INC (NASDAQ), ARAVIVE INC (NASDAQ), AIKIDO PHARMA INC (NASDAQ), ELOXX PHARMACEUTICALS INC (NASDAQ), CHIMERIC THERAPEUTICS LTD (ASX), LUMOS PHARMA INC (NASDAQ), ONCONOVA THERAPEUTICS INC (NASDAQ), CALITHERA BIOSCIENCES INC (NASDAQ), SPRUCE BIOSCIENCES INC (NASDAQ), CELYAD ONCOLOGY SPON ADS EACH REPR 1 ORD SHS (NASDAQ), MERRIMACK PHARMACEUTICALS INC (NASDAQ), PATRYS LIMITED (ASX), RHINOMED LIMITED (ASX), CYNATA THERAPEUTICS LTD (ASX), MEMPHASYS LTD (ASX), AETERNA ZENTARIS INC (NASDAQ), MONOPAR THERAPEUTICS INC (NASDAQ), ADVAXIS INC (NASDAQ), BIOMX INC (NYSE American), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), AZIYO BIOLOGICS INC (NASDAQ), VACCINEX INC (NASDAQ), TRACON PHARMACEUTICALS INC (NASDAQ), FORWARD PHARMA AS SPON ADS EACH REP 14 ORD SHS (NASDAQ), CHIA TAI ENTERPRISES INTL LTD (HKEx), WINDTREE THERAPEUTICS INC (NASDAQ), BRIGHT MINDS BIOSCIENCES INC (NASDAQ), BIOTRON (ASX), ENDURANCE RP LTD (HKEx), PRECIPIO INC (NASDAQ), CYCLO THERAPEUTICS INC (NASDAQ), NABRIVA THERAPEUTICS PLC (NASDAQ), SYNTHETIC BIOLOGICS INC (NYSE American), ALTERITY THERAPEUTICS LIMITED (ASX), COHBAR INC (NASDAQ), APPLIED DNA SCIENCES INC (NASDAQ), EXICURE INC (NASDAQ), CELLECTAR BIOSCIENCES INC (NASDAQ), NEUROBO PHARMACEUTICALS INC (NASDAQ), BON NAT LIFE LTD (NASDAQ), GENETIC TECHNOLOGIES (ASX), APTEVO THERAPEUTICS INC (NASDAQ), ORGANOVO HLDGS INC (NASDAQ), MINERVA NEUROSCIENCES INC (NASDAQ), DIFFUSION PHARMACEUTICALS INC (NASDAQ), INDIA GLOBALIZATION CAPITAL INC (NYSE American), ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS (NASDAQ), KIROMIC BIOPHARMA INC (NASDAQ), ARGENICA THERAPEUTICS LIMITED (ASX), FORTE BIOSCIENCES INC (NASDAQ), CATALYST BIOSCIENCES INC (NASDAQ), ENDRA LIFE SCIENCES INC (NASDAQ), PULMATRIX INCORPORATED (NASDAQ), METACRINE INC (NASDAQ), TRANSCODE THERAPEUTICS INC (NASDAQ), INVEX THERAPEUTICS LTD NPV (ASX), CYCLACEL PHARMACEUTICALS INC (NASDAQ), MICROBOT MEDICAL INC (NASDAQ), LIMINAL BIOSCIENCES INC (NASDAQ), IDERA PHARMACEUTICALS INC (NASDAQ), GENETIC TECHNOLOGIES SPON ADS EA REP 600 ORD SHS(R/S) (NASDAQ), ALIMERA SCIENCES INC (NASDAQ), BIOCARDIA INC (NASDAQ), NEUROSCIENTIFIC BIOPHARMA LTD (ASX), BIOSINO BIO-TECHNOLOGY AND SCIENCE (HKEx), ENSYSCE BIOSCIENCES INC (NASDAQ), SOLIGENIX INC (NASDAQ), ARCA BIOPHARMA INC (NASDAQ), CONTANGO ASSET MANAGEMENT LIMITED (ASX), ZIVO BIOSCIENCE INC (NASDAQ), SONNET BIOTHERAPEUTICS HLDGS INC (NASDAQ), BIO-PATH HOLDINGS INC (NASDAQ), ACORDA THERAPEUTICS INC (NASDAQ), PALISADE BIO INC (NASDAQ), TERRAGEN HOLDINGS LIMITED (ASX), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), MIDATECH PHARMA PLC SPON ADS EACH REP 5 ORD SHS(R/S) (NASDAQ), ORAGENICS INC (NYSE American), GEOVAX LABS INC (NASDAQ), BENITEC BIOPHARMA INC (NASDAQ), AMPLIA THERAPEUTICS LTD (ASX), CAN FITE BIOPHARMA LTD SPON ADS EA REP 30 ORD SHS(POST REV SPL (NYSE American), ALTAMIRA THERAPEUTICS LTD (NASDAQ), ADITX INC (NASDAQ), ANPAC BIO MEDICAL SCIENCE CO LTD SPON ADS EACH REPR 1 ORD SHS CLASS A (NASDAQ), BIORESTORATIVE THERAPIES INC (NASDAQ), FIRST WAVE BIOPHARMA INC (NASDAQ), AVECHO BIOTECHNOLOGY LTD (ASX), LIXTE BIOTECHNOLOGY HOLDINGS INC (NASDAQ), HISTOGEN INC (NASDAQ), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ), XENETIC BIOSCIENCES INC (NASDAQ), PHIO PHARMACEUTICALS CORP (NASDAQ), QUOIN PHARMACEUTICALS LTD SPON ADS EA REP 400 ORD SHS (NASDAQ), XTL BIOPHARMACEUTICALS LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), REGENEUS LTD (ASX), BELLICUM PHARMACEUTICALS (NASDAQ), ADALTA LTD (ASX), SENESTECH INC (NASDAQ), CRYOSITE (ASX), HOLISTA COLLTECH LIMITED (ASX), NANOLLOSE LTD (ASX), HAO WEN HOLDINGS LIMITED (HKEx), CONSTELLATION TECHNOLOGIES LTD (ASX), ANATARA LIFESCIENCES LTD (ASX), NOVABAY PHARMACEUTICALS INC (NYSE American), LIVING CELL TECHNOLOGIES (ASX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

More Information Available

More information is available to our subscribers, including:

  • Consensus Estimates
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.